Morgan Stanley Maintains Equal-Weight on Aflac, Raises Price Target to $98
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Nigel Dally maintains an Equal-Weight rating on Aflac and raises the price target from $91 to $98.
August 19, 2024 | 5:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Morgan Stanley has maintained its Equal-Weight rating on Aflac but increased the price target from $91 to $98, indicating a positive outlook.
The increase in price target from $91 to $98 by Morgan Stanley suggests a positive outlook for Aflac, which could lead to a short-term increase in stock price. The maintained Equal-Weight rating indicates a balanced view, but the raised target price is a positive signal.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100